Immunohistochemical
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue, using p44/42 MAPK Antibody. The picture on the right is treated with the synthesized peptide.
Western blot
Western blot analysis of extracts from HeLa cells, using p44/42 MAPK Antibody. The lane on the right is treated with the synthesized peptide
WB
(A) Expression of MAPKs and NF-κB in the lung tissues.
WB
(A and B) Western blotting bands (a) and their statistical analyses (b) of c-Fos (A, n = 6) and pERK1/2 (B, n = 7).
WB
(B and C) Western blotting bands (a) and the summary graphs (b) showing the effects of BAO and BC on pERK1/2 expression in SON (B) and PVN (C).
WB
(B) Western blot bands (left panel) and the summary graphs (right panel) showing the expression of pERK1/2 under different experimental conditions.
WB
(A) Representative Western blotting bands (a) and the summary graph (b) showing the effects of CD and of CD-IAO on phosphorylated extracellular signal-regulated protein kinase 1/2 (pERK 1/2) protein expression.
WB
(A) Representative Western blotting bands (a) and the summary graph (b) showing the effects of CD and of CD-IAO on pERK 1/2 protein expression.